These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 30694166)
1. Hepatocellular Carcinoma versus Other Hepatic Malignancy in Cirrhosis: Performance of LI-RADS Version 2018. Kim YY; Kim MJ; Kim EH; Roh YH; An C Radiology; 2019 Apr; 291(1):72-80. PubMed ID: 30694166 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic Performance of LI-RADS Version 2018 for Evaluation of Pediatric Hepatocellular Carcinoma. Khanna G; Chavhan GB; Schooler GR; Fraum TJ; Alazraki AL; Squires JH; Salter A; Podberesky DJ; Towbin AJ Radiology; 2021 Apr; 299(1):190-199. PubMed ID: 33620289 [TBL] [Abstract][Full Text] [Related]
3. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules. Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F; J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247 [TBL] [Abstract][Full Text] [Related]
4. How to utilize LR-M features of the LI-RADS to improve the diagnosis of combined hepatocellular-cholangiocarcinoma on gadoxetate-enhanced MRI? Lee HS; Kim MJ; An C Eur Radiol; 2019 May; 29(5):2408-2416. PubMed ID: 30552477 [TBL] [Abstract][Full Text] [Related]
5. MR versus CEUS LI-RADS for Distinguishing Hepatocellular Carcinoma from other Hepatic Malignancies in High-Risk Patients. Huang Z; Zhou P; Li S; Li K Ultrasound Med Biol; 2021 May; 47(5):1244-1252. PubMed ID: 33610338 [TBL] [Abstract][Full Text] [Related]
6. Differentiation of Hepatocellular Carcinoma from Other Hepatic Malignancies in Patients at Risk: Diagnostic Performance of the Liver Imaging Reporting and Data System Version 2014. Fraum TJ; Tsai R; Rohe E; Ludwig DR; Salter A; Nalbantoglu I; Heiken JP; Fowler KJ Radiology; 2018 Jan; 286(1):158-172. PubMed ID: 28853673 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma. Huang JY; Li JW; Lu Q; Luo Y; Lin L; Shi YJ; Li T; Liu JB; Lyshchik A Radiology; 2020 Feb; 294(2):329-339. PubMed ID: 31793849 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS. Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394 [TBL] [Abstract][Full Text] [Related]
9. Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma? Huang JY; Li JW; Ling WW; Li T; Luo Y; Liu JB; Lu Q World J Gastroenterol; 2020 Jul; 26(27):3938-3951. PubMed ID: 32774068 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic Performance of LI-RADS Version 2018, LI-RADS Version 2017, and OPTN Criteria for Hepatocellular Carcinoma. Kierans AS; Song C; Gavlin A; Roudenko A; Lu L; Askin G; Hecht EM AJR Am J Roentgenol; 2020 Nov; 215(5):1085-1092. PubMed ID: 32877248 [No Abstract] [Full Text] [Related]
11. LI-RADS Version 2017 versus Version 2018: Diagnosis of Hepatocellular Carcinoma on Gadoxetate Disodium-enhanced MRI. Lee SM; Lee JM; Ahn SJ; Kang HJ; Yang HK; Yoon JH Radiology; 2019 Sep; 292(3):655-663. PubMed ID: 31310175 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the accuracy of AASLD and LI-RADS criteria for the non-invasive diagnosis of HCC smaller than 3 cm. Ronot M; Fouque O; Esvan M; Lebigot J; Aubé C; Vilgrain V J Hepatol; 2018 Apr; 68(4):715-723. PubMed ID: 29274407 [TBL] [Abstract][Full Text] [Related]
13. Distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma in patients with and without risks: the evaluation of the LR-M criteria of contrast-enhanced ultrasound liver imaging reporting and data system version 2017. Li F; Li Q; Liu Y; Han J; Zheng W; Huang Y; Zheng X; Cao L; Zhou JH Eur Radiol; 2020 Jan; 30(1):461-470. PubMed ID: 31297632 [TBL] [Abstract][Full Text] [Related]
14. Liver Imaging Reporting and Data System (LI-RADS) v2018: diagnostic value of ancillary features favoring malignancy in hypervascular observations ≥ 10 mm at intermediate (LR-3) and high probability (LR-4) for hepatocellular carcinoma. Cannella R; Vernuccio F; Sagreiya H; Choudhury KR; Iranpour N; Marin D; Furlan A Eur Radiol; 2020 Jul; 30(7):3770-3781. PubMed ID: 32107603 [TBL] [Abstract][Full Text] [Related]
15. Differentiation of hepatocellular carcinoma from intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma in high-risk patients matched to MR field strength: diagnostic performance of LI-RADS version 2018. Zou X; Luo Y; Morelli JN; Hu X; Shen Y; Hu D Abdom Radiol (NY); 2021 Jul; 46(7):3168-3178. PubMed ID: 33660040 [TBL] [Abstract][Full Text] [Related]
16. Imaging Features of Biphenotypic Primary Liver Carcinoma (Hepatocholangiocarcinoma) and the Potential to Mimic Hepatocellular Carcinoma: LI-RADS Analysis of CT and MRI Features in 61 Cases. Potretzke TA; Tan BR; Doyle MB; Brunt EM; Heiken JP; Fowler KJ AJR Am J Roentgenol; 2016 Jul; 207(1):25-31. PubMed ID: 26866746 [TBL] [Abstract][Full Text] [Related]
17. Imaging features of hepatocellular carcinoma compared to intrahepatic cholangiocarcinoma and combined tumor on MRI using liver imaging and data system (LI-RADS) version 2014. Horvat N; Nikolovski I; Long N; Gerst S; Zheng J; Pak LM; Simpson A; Zheng J; Capanu M; Jarnagin WR; Mannelli L; Do RKG Abdom Radiol (NY); 2018 Jan; 43(1):169-178. PubMed ID: 28765978 [TBL] [Abstract][Full Text] [Related]
18. Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis. Vidili G; Arru M; Solinas G; Calvisi DF; Meloni P; Sauchella A; Turilli D; Fabio C; Cossu A; Madeddu G; Babudieri S; Zocco MA; Iannetti G; Di Lembo E; Delitala AP; Manetti R World J Gastroenterol; 2022 Jul; 28(27):3488-3502. PubMed ID: 36158272 [TBL] [Abstract][Full Text] [Related]
19. LI-RADS Version 2018 Targetoid Appearances on Gadoxetic Acid-Enhanced MRI: Interobserver Agreement and Diagnostic Performance for the Differentiation of HCC and Non-HCC Malignancy. Min JH; Lee MW; Park HS; Lee DH; Park HJ; Lee JE; Park SJ; Kim SS; Park SH; Ha SY; Hwang JA; Cha DI; Park B AJR Am J Roentgenol; 2022 Sep; 219(3):421-432. PubMed ID: 35319906 [No Abstract] [Full Text] [Related]
20. LR-M Observations on Contrast-Enhanced Ultrasound: Detection of Hepatocellular Carcinoma Using Additional Features in Comparison With Current LI-RADS Criteria. Xian MF; Huang Y; Xie WX; Pan KM; Zeng D; Huang H; Li MD; Xie XY; Kuang M; Lu MD; Chen LD; Wang W AJR Am J Roentgenol; 2022 Jul; 219(1):76-85. PubMed ID: 34910538 [No Abstract] [Full Text] [Related] [Next] [New Search]